Diligence memo · auto-generated · as of July 2, 2026
Land Medicine Inc.
Land Medicine Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Land Medicine Inc. operates in Pharmaceuticals, based in CHARLESTOWN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Land Medicine Inc. has raised $17M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $17M on 2024-12-23.
Most recent recorded round closed around 2024-12-23.
Valuation (modeled)modeled
Provath models Land Medicine Inc. at approximately $98M (range $36M–$160M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.75× the median modeled value of Series B Pharmaceuticals companies in 2022–2024 (51 peers) — value vs value, same stage and era. Within the normal band (75% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 18 mo ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 63% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 54% of those peers.
Closest niche peers: MedAvail Holdings, Inc., Revalesio Corp, Kinaset Therapeutics, Inc., Venatorx Pharmaceuticals, Inc., Cxl Ophthalmics, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.